KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Takeda Pharmaceutical (TAK) Treasury Shares (2018 - 2026)

Takeda Pharmaceutical has reported Treasury Shares over the past 9 years, most recently at -$313.3 million for Q1 2026.

  • For Q1 2026, Treasury Shares rose 36.12% year-over-year to -$313.3 million; the TTM value through Mar 2026 reached -$313.3 million, up 36.12%, while the annual FY2026 figure was -$326.4 million, 33.55% up from the prior year.
  • Treasury Shares was $209917.6 for Q1 2023 at Takeda Pharmaceutical, down from $274426.1 in the prior quarter.
  • Across five years, Treasury Shares topped out at $274426.1 in Q1 2022 and bottomed at $92886.0 in Q1 2019.
  • The 5-year median for Treasury Shares is $170904.3 (2020), against an average of $174247.0.
  • Year-over-year, Treasury Shares surged 77.42% in 2022 and then crashed 241.78% in 2025.
  • Over 5 years, Treasury Shares stood at $998.2 million in 2022, then decreased by 24.03% to $758.4 million in 2023, then tumbled by 54.39% to $345.9 million in 2024, then crashed by 241.78% to -$490.4 million in 2025, then soared by 36.12% to -$313.3 million in 2026.
  • The last three reported values for Treasury Shares were -$313.3 million (Q1 2026), -$490.4 million (Q1 2025), and $345.9 million (Q1 2024) per Business Quant data.